Abstract:411 Objectives: Acute kidney injury (AKI) often complicates treatment outcomes of hospitalized patients, which manifests as decreased kidney glomerular filtration and results in toxic chemicals accumulating in blood. The pathogenesis of many AKI conditions has implicated reactive oxygen species (ROS) as a major factor. Ongoing research has shown that nanomaterials are superior to their small molecule counterparts due to the ability to control their biodistribution and intrinsic scavenging abilities. We found that selenium-doped carbon quantum dots localize in the kidneys of mice and eliminate ROS to treat and prevent AKI. Methods: Carbon quantum dots with high antioxidant capacity were prepared by doping selenium (SeCQDs) through a hydrothermal treatment. PET imaging of SeCQDs was preformed to evaluate biodistribution using Zr-89 (half life: 78.4 h) after functionalizing with deferoxamine (DFO; 89Zr-DFO-SeCQDs). AKI was induced by intramuscular injection of 50% glycerol into the hindlimbs (8 mL/kg) as well as by intraperitoneal injection of cisplatin (20 mg/kg) in mice. An equivalent dose of amifostine, an FDA approved drug that acts through a similar mechanism for AKI treatment, was used to demonstrate the superiority of SeCQDs for AKI therapy. Results: SeCQDs were found to rapidly and exclusively accumulate in kidneys as the uptake was 25.37±4.51 %ID/g at 4 h post-injection (p.i.) following intravenous administration and up to 72 h p.i. (20.47 %ID/g) using PET imaging (n=3). Blood serum creatinine (CRE) and blood urea nitrogen (BUN) as well as H&E staining of kidney tissue were used to validate therapeutic effects in the AKI models. Therapeutic doses of SeCQDs were found to be 1 µg per mouse for AKI induced using 50% glycerol. Serum CRE and BUN were markedly lower for SeCQDs (0.38±0.08 and 44.2±11.7 mg/dL, respectively) compared to PBS negative controls (1.76±0.42 and 169.2±55.1 mg/dL, respectively) (n=5 for all groups). Moreover, cisplatin-induced AKI was prevented by administering 50 µg of SeCQDs per mouse as determined by serum CRE and BUN for SeCQDs (0.5±0.07 and 93.4±53.3 mg/dL, respectively) compared to PBS negative controls (2.24±0.4 and 199.2±36.4 mg/dL, respectively) (n=5 for all groups). Amifostine at an equivalent dose in each AKI model (based on selenium and sulfur composition) was ineffective to treat either glycerol- (BUN: 129.4±45 mg/dL, CRE: 1.06±0.4 mg/dL) or cisplatin-induced AKI (BUN: 174±24.3 mg/dL, CRE: 2±0.59 mg/dL) (n=5 for all groups). Conclusion: PET imaging elucidated that SeCQDs predominately accumulate in kidneys for as long as 72 h. The high renal accumulation of SeCQDs proved a highly effective therapy for the treatment of AKI induced using 50% glycerol and prevention of AKI from cisplatin due to its antioxidant properties. In the same animal models, amifostine was unsuccessful in AKI treatment and demonstrates the promise of utilizing nanomaterials over small molecule drugs to treat kidney diseases.

Selenium nanoparticles alleviate renal ischemia/reperfusion injury by inhibiting ferritinophagy via the XBP1/NCOA4 pathway

Selenium nanoparticles alleviate ischemia reperfusion injury-induced acute kidney injury by modulating GPx-1/NLRP3/Caspase-1 pathway

Selenium binding protein 1 protects renal tubular epithelial cells from ferroptosis by upregulating glutathione peroxidase 4

Fullerenols as efficient ferroptosis inhibitor by targeting lipid peroxidation for preventing drug-induced acute kidney injury

Selenium nanoparticles alleviates cadmium induced hepatotoxicity by inhibiting ferroptosis and oxidative stress in vivo and in vitro

Targeting iron metabolism using gallium nanoparticles to suppress ferroptosis and effectively mitigate acute kidney injury

Porous Se@SiO2 Nanospheres Attenuate Ischemia/reperfusion (I/r)-Induced Acute Kidney Injury (AKI) and Inflammation by Antioxidative Stress.

Selenium nanoparticles derived from Proteus mirabilis YC801 alleviate oxidative stress and inflammatory response to promote nerve repair in rats with spinal cord injury

Ferritinophagy is Involved in the Zinc Oxide Nanoparticles-Induced Ferroptosis of Vascular Endothelial Cells

Renal-Accumulating Selenium-Doped Carbon Quantum Dots Treat Acute Kidney Injury in Mice

Melanin-like nanoparticles alleviate ischemia-reperfusion injury in the kidney by scavenging reactive oxygen species and inhibiting ferroptosis

Ultrasmall Nanodots with Dual Anti‐Ferropototic Effect for Acute Kidney Injury Therapy

Reactive Oxygen Species-Scavenging Mesoporous Poly(tannic acid) Nanospheres Alleviate Acute Kidney Injury by Inhibiting Ferroptosis

Ginsenoside Rg1 Suppresses Ferroptosis of Renal Tubular Epithelial Cells in Sepsis-induced Acute Kidney Injury via the FSP1-CoQ10-NAD(P)H Pathway

Selenium Alleviates Cerebral Ischemia/Reperfusion Injury by Regulating Oxidative Stress, Mitochondrial Fusion and Ferroptosis

Silica nanoparticles induce ferroptosis of HUVECs by triggering NCOA4-mediated ferritinophagy

Isoliquiritigenin attenuates septic acute kidney injury by regulating ferritinophagy-mediated ferroptosis

Simultaneous Elimination of Reactive Oxygen Species and Activation of Nrf2 by Ultrasmall Nanoparticles to Relieve Acute Kidney Injury

Polyacrylic Acid‐Coated Selenium‐Doped Carbon Dots Inhibit Ferroptosis to Alleviate Chemotherapy‐Associated Acute Kidney Injury

Protection Against Ischemia/reperfusion–induced Renal Injury by Co–treatment with Erythropoietin and Sodium Selenite

Inhibition of the NADPH Oxidase Pathway Reduces Ferroptosis during Septic Renal Injury in Diabetic Mice